-
Product Insights
New![]()
Safe Harbor
Safe Harbor is a Hydro project located in Pennsylvania, United States. The project is owned by Brookfield Renewable Partners LP and was developed by Safe Harbor Water Power Corp. The project came online in 1931. Empower your strategies with our Safe Harbor report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain...
-
Track & Monitor
New![]()
Innovation in automotive: Crash-safe battery protection
Why settle for outdated information when you can stay ahead of the curve with our comprehensive report? Our team of industry experts has meticulously researched and analyzed the latest trends, innovations, and emerging technologies in the automotive industry’s Crash-safe battery protection innovations. By leveraging our report, you'll gain invaluable insights that can revolutionize your business strategies and give you a competitive edge. Why Choose Our Report? Unparalleled Expertise: Our research team consists of seasoned analysts with deep knowledge and experience...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – CNP-201 in Peanut Allergy
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.CNP-201 in Peanut Allergy Drug Details:CNP-201 is under development for the treatment of peanut allergy. The...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – NT-501 in Glaucoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. NT-501 in Glaucoma Drug Details: NT-501 is under development for the treatment of glaucoma and...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – SYNB-1618 in Phenylketonuria (PKU)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.SYNB-1618 in Phenylketonuria (PKU) Drug Details:SYNB-1618 is under development for the treatment of phenylketonuria (PKU). SYNB1618...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – OMN-6 in Hospital Acquired Pneumonia (HAP)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.OMN-6 in Hospital Acquired Pneumonia (HAP) Drug Details:OMN-6 is under development for the treatment of multi-drug...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – OMN-6 in Urinary Tract Infections
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.OMN-6 in Urinary Tract Infections Drug Details:OMN-6 is under development for the treatment of multi-drug resistant...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Ropivacaine ER in Post-Operative Pain
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Ropivacaine ER in Post-Operative PainDrug Details:Ropivacaine ER (PRF-110) is under development for the treatment of post-operative...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Hypericin Sodium in Mycosis Fungoides
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Hypericin Sodium in Mycosis FungoidesDrug Details:Hypericin (SGX-301, HBP-347) is under development for the treatment of cutaneous...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – OMN-6 in Acinetobacter Infections
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.OMN-6 in Acinetobacter InfectionsDrug Details:OMN-6 is under development for the treatment of multi-drug resistant Acinetobacter baumannii...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.